ERNA vs ILMN · P/E 0.0, rev $582.0K vs rev $4.34B
Eterna Therapeutics Inc (ERNA) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the ERNA and ILMN stock pages for the full models.
Not investment advice.